Pseudomonas diseases.
D000818:Animals; D000907:Antibodies, Bacterial / Q000302:isolation & purification; D000942:Antigens, Bacterial / Q000302:isolation & purification; D002228:Carbenicillin / Q000008:administration & dosage / Q000627:therapeutic use; D003428:Cross Infection / Q000453:epidemiology; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D051379:Mice; D010403:Penicillin Resistance; D010587:Phagocytosis; D011014:Pneumonia / Q000382:microbiology; D011552:Pseudomonas Infections / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D018805:Sepsis / Q000382:microbiology; D012877:Skin Manifestations; D014481:United States; D014552:Urinary Tract Infections / Q000382:microbiology; D005719:gamma-Globulins / Q000008:administration & dosage
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D005839:Gentamicins; D005719:gamma-Globulins; D002228:Carbenicillin